Nicotinic Receptors and Schizophrenia

NCT02538081 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

FED

Sponsor class

Stopped Withdrawn

Conditions

Schizophrenia

Interventions

DRUG: Risperidone plus Placebo
DRUG: Risperidone plus DMXB-A

Sponsor

VA Office of Research and Development

Collaborators

[object Object]